Jump to navigation Jump to search
Mechanism of action
Diseases for which it is used
History of changes in PMDA indication
- 2020-03-25: Newly indicated for the treatment of relapsed or refractory primary central nervous system (CNS) lymphoma.
- 2020-08-21: New indications for the treatment of Waldenström's macroglobulinemia and lymphoplasmacytic lymphoma.
Also known as
- Code name: GS-4059
- Brand name: Velexbru